Tongxinluo Capsule in Ischemic Stroke Patients´╝łTISS)

Not yet recruiting

Phase 4 Results N/A

Summary of Purpose

The purpose of this study is to assess the effects in improving life self-care ability of stroke patients after taking Tongxinluo Capsule(within 72 hours after onset) versus Placebos for 90 days.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 7 August 2013.

1 Sep 2013 7 Aug 2013 1 Apr 2015 1 Dec 2015 1 Aug 2013 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Conditions

Sponsors

Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment

Contacts